Skip to content

CareDx

US · CDNA #2371 by market cap Listed 1970
70.00 -1.92 -2.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Rating change
    Craig-Hallum Upgrades CareDx(CDNA.US) to Buy Rating, Raises Target Price to $64
    \u5e02\u573a\u8d44\u8baf · 2026/8/3
  • Rating change
    Craig-Hallum Maintains CareDx(CDNA.US) With Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/6/25
  • Rating change
    BTIG Maintains CareDx(CDNA.US) With Buy Rating, Raises Target Price to $74
    \u5e02\u573a\u8d44\u8baf · 2026/9/24
  • Rating change
    H.C. Wainwright Maintains CareDx(CDNA.US) With Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/4/30
  • Rating change
    William Blair Maintains CareDx(CDNA.US) With Hold Rating, Announces Target Price $21.91
    \u5e02\u573a\u8d44\u8baf · 2026/4/29
  • Rating change
    William Blair Maintains CareDx(CDNA.US) With Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/8/3
  • Rating change
    CCORF Maintains CareDx(CDNA.US) With Buy Rating, Raises Target Price to $80
    \u5e02\u573a\u8d44\u8baf · 2026/10/19
  • Piper Sandler Initiates CareDx(CDNA.US) With Buy Rating, Announces Target Price $100
    \u5e02\u573a\u8d44\u8baf · 2026/11/11
  • Rating change
    H.C. Wainwright Maintains CareDx(CDNA.US) With Hold Rating, Announces Target Price $46
    \u5e02\u573a\u8d44\u8baf · 2026/7/31
  • Rating change
    A Quick Look at Today's Ratings for CareDx(CDNA.US), With a Forecast Between $35 to $45
    \u5e02\u573a\u8d44\u8baf · 2026/7/17
  • Rating change
    CCORF Initiates CareDx(CDNA.US) With Buy Rating, Announces Target Price $65
    \u5e02\u573a\u8d44\u8baf · 2026/9/2
  • H.C. Wainwright Maintains CareDx(CDNA.US) With Hold Rating, Raises Target Price to $90
    \u5e02\u573a\u8d44\u8baf · 2026/11/2
  • Rating change
    H.C. Wainwright Maintains CareDx(CDNA.US) With Hold Rating, Announces Target Price $25
    \u5e02\u573a\u8d44\u8baf · 2026/3/9
  • BTIG Maintains CareDx(CDNA.US) With Buy Rating, Raises Target Price to $81
    \u5e02\u573a\u8d44\u8baf · 2026/10/27
  • Rating change
    BTIG Maintains CareDx(CDNA.US) With Buy Rating, Raises Target Price to $28
    \u5e02\u573a\u8d44\u8baf · 2026/4/29
  • Rating change
    BTIG Maintains CareDx(CDNA.US) With Buy Rating, Raises Target Price to $60
    \u5e02\u573a\u8d44\u8baf · 2026/8/6
  • Rating change
    BTIG Maintains CareDx(CDNA.US) With Buy Rating, Raises Target Price to $26
    \u5e02\u573a\u8d44\u8baf · 2026/2/26
  • CCORF Maintains CareDx(CDNA.US) With Buy Rating, Raises Target Price to $99
    \u5e02\u573a\u8d44\u8baf · 2026/10/30
  • Rating change
    A Quick Look at Today's Ratings for CareDx(CDNA.US), With a Forecast Between $21.91 to $28
    \u5e02\u573a\u8d44\u8baf · 2026/4/30
  • CareDx(CDNA.US) Officer Sells US$4.82 Million in Common Stock
    \u5e02\u573a\u8d44\u8baf · 2026/11/10
  • Rating change
    Wells Fargo Maintains CareDx(CDNA.US) With Hold Rating, Raises Target Price to $21
    \u5e02\u573a\u8d44\u8baf · 2026/2/25
  • Rating change
    Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Atai Beckley N.V. (ATAI)
    TipRanks · 2026/2/25
  • GUIDANCE: (CDNA) CareDx Expects 2026 Revenue Range $520M - $530M, Vs. FactSet Est of $495.1M
    MT Newswires · 2026/10/30
  • Rating change
    Craig-Hallum Upgrades CareDx(CDNA.US) to Buy Rating
    \u5e02\u573a\u8d44\u8baf · 2026/1/14
  • Rating change
    Craig-Hallum Downgrades CareDx(CDNA.US) to Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/1/23

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:25 · For reference only, not investment advice and not tailored to your situation.

CareDx discussion 0 comments

Add a comment